Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0EP9A
|
|||
| Drug Name |
Dinutuximab
|
|||
| Indication | Small-cell lung cancer [ICD-11: 2C25.Y; ICD-9: 162.9] | Phase 2/3 | [1] | |
| Company |
United Therapeutics Silver Spring, MD
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.